Medical Device & IVD Consultancy Services 

A medical device and IVD consultancy gives manufacturers regulatory, quality, and clinical expertise without building every discipline in-house. Companies typically bring one in when a submission deadline is close, a portfolio needs remediation against MDR or IVDR, or an in-house team lacks capacity for a specific stage of the process.

Both regulations reclassified many devices into higher-risk categories than under the previous directives, which expanded the clinical evidence and notified body review each product now needs. Notified body capacity hasn't kept pace with that shift, so timelines increasingly depend on securing a review slot as much as on the technical work itself. Coordinating regulatory, quality, and clinical work across separate vendors adds a further layer of delay, since a finding in one workstream, a classification change or a clinical evidence gap, tends to ripple into the others.

What makes Qserve's consultancy approach different

Qserve's consultancy combines regulatory strategy, quality assurance, and clinical strategy in one advisory team, instead of routing each discipline to a separate specialist firm. Consultants bring hands-on notified body and industry experience, so recommendations reflect what an assessor will actually expect, not just what the regulation states on paper.

That combination matters because the disciplines are rarely independent in practice. A classification decision shapes the clinical evidence plan; a clinical evidence gap shapes what a quality system needs to demonstrate at audit. Qserve's consultants work across:

• Medical Devices 

• In-Vitro Diagnostics (IVD)

• Combination Devices

• Companion Diagnostics (CDx)

Advice accounts for how a product's classification affects every downstream discipline.

When to bring Qserve's consultancy team in

Teams typically engage Qserve's consultancy before a notified body submission, when remediating an existing MDR or IVDR technical file, when entering a new market, or when a regulatory or quality role sits vacant. Startups often bring Qserve in earlier, to build the regulatory and quality foundation from the ground up.

• Preparing a first CE mark or FDA submission

• Remediating an existing MDR or IVDR technical file

• Entering a new market or region

• Covering a vacant regulatory or quality role

• Assessing regulatory risk ahead of an acquisition

• Building a regulatory and quality function from scratch